Publications by authors named "Xinya Lv"

Claim this Profile
P
Pyrimidine-based dual-target inhibitors targeting epidermal growth factor receptor for overcoming drug resistance in cancer therapy(2006-present).
Yufeng An, Xinya Lv, Shidi Xu, Heqing Li, Pengwu Zheng

Eur J Med Chem· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revealing 5-(3,5-difluorobenzyl)-1H-indazole as the active pharmacophore of ALK/ROS1 dual inhibitors through theoretical calculations and biological activity evaluations.
Xiaoling Huang, Shidi Xu, Yufeng An, Xinya Lv, Lulu Tian

Bioorg Chem· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fused in silico and bioactivity evaluation method for drug discovery: T001-10027877 was identified as an antiproliferative agent that targets EGFR and EGFR.
Linxiao Wang, Xiaoling Huang, Shidi Xu, Yufeng An, Xinya Lv, Qiaoli Lv

BMC Chem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis